当前位置:首页 - 行情中心 - 奇正藏药(002287) - 财务分析 - 现金流量表

奇正藏药

(002287)

  

流通市值:120.29亿  总市值:120.56亿
流通股本:5.29亿   总股本:5.30亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,214,904,266.351,194,303,276.121,034,527,061.14233,203,887.28
收到的税费返还18,078,152.6410,704,703.54,539,795.374,539,795.37
收到其他与经营活动有关的现金232,219,681.33129,461,021.0222,178,070.1421,132,703.17
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,465,202,100.321,334,469,000.641,061,244,926.65258,876,385.82
购买商品、接受劳务支付的现金174,484,354.1110,353,957.0665,513,355.339,896,735.94
支付给职工以及为职工支付的现金523,142,571.26377,757,098.97253,676,521.29135,887,395.92
支付的各项税费302,406,055.17199,670,705.83118,465,897.7861,178,557.99
支付其他与经营活动有关的现金771,764,035.45529,658,366.87397,434,520.28203,483,088.92
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,771,797,015.981,217,440,128.73835,090,294.65440,445,778.77
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额693,405,084.34117,028,871.91226,154,632-181,569,392.95
二、投资活动产生的现金流量:
收回投资收到的现金1,138,149,0911,055,105,294.17650,554,500400,000,000
取得投资收益收到的现金278,467,705.3527,723,239.4920,822,908.6712,736,886.07
处置固定资产、无形资产和其他长期资产收回的现金净额36,612.9635,72835,728-
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,416,653,409.311,082,864,261.66671,413,136.67412,736,886.07
购建固定资产、无形资产和其他长期资产支付的现金234,814,015.37106,294,504.7864,915,069.7626,784,189.79
投资支付的现金1,492,430,0001,492,430,0001,022,430,000582,430,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,727,244,015.371,598,724,504.781,087,345,069.76609,214,189.79
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-310,590,606.06-515,860,243.12-415,931,933.09-196,477,303.72
三、筹资活动产生的现金流量:
取得借款收到的现金750,000,000750,000,000500,000,000100,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计750,000,000750,000,000500,000,000100,000,000
偿还债务支付的现金951,800,000349,300,000149,046,041.67-
分配股利、利润或偿付利息支付的现金220,047,048.2215,474,295.639,395,432.673,413,261.64
支付其他与筹资活动有关的现金10,649,672.351,178,199.28618,324.28511,269.28
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,182,496,720.55565,952,494.91159,059,798.623,924,530.92
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-432,496,720.55184,047,505.09340,940,201.3896,075,469.08
四、汇率变动对现金及现金等价物的影响614,638.011,120,488.971,355,560.08-459,647.03
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-49,067,604.26-213,663,377.15152,518,460.37-282,430,874.62
加:期初现金及现金等价物余额437,571,379.17437,571,379.17437,571,379.17437,571,379.17
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额388,503,774.91223,908,002.02590,089,839.54155,140,504.55
补充资料:
净利润579,177,744.64-310,700,202.59-
资产减值准备-82,643.85-1,318,537.39-
固定资产和投资性房地产折旧57,505,571.16-26,142,895.54-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧57,505,571.16-26,142,895.54-
无形资产摊销27,929,078.09-13,263,212.38-
长期待摊费用摊销2,531,474.16-1,557,006.38-
处置固定资产、无形资产和其他长期资产的损失-318,156.83--143,431.27-
固定资产报废损失284,354.32-81,585.18-
公允价值变动损失-37,074,168.19--28,048,327.52-
财务费用63,069,765.65-35,645,747.05-
投资损失-32,235,258.25--69,099,357.05-
递延所得税-24,250,594.82-9,135,904.56-
其中:递延所得税资产减少-8,798,271.1--1,587,022.01-
递延所得税负债增加-15,452,323.72-10,722,926.57-
存货的减少-28,458,644.95--25,750,446.11-
经营性应收项目的减少41,953,850.25--435,670,948.39-
经营性应付项目的增加9,787,624.72-385,036,696.73-
其他24,507,749.74---
现金的期末余额388,503,774.91-590,089,839.54-
减:现金的期初余额437,571,379.17-437,571,379.17-
公告日期2024-04-192023-10-272023-08-252023-04-28
审计意见(境内)标准无保留意见
TOP↑